Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TEVA
$39.53
+0.56%
TEVA
· Teva Pharmaceutical Industries Ltd
Market Cap
$45.67B
Shares
1.17B
Volume · Oct 2
4.77M
Avg daily vol (3M)
5.34M
All webcasts
Earnings call · FY2023 Q1
Teva Pharmaceutical Industries Ltd (TEVA) Q1 2023 Earnings Call
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$3.66B
+0% YoY
Diluted EPS
-$0.20
Gross margin
43.2%
-4.3 pp YoY
Net income
-$220.00M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 10, 2023.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Revenues
Initiated
Full year 2023
|
$14.8B – $15.4B | — | $15.85B above | |
|
Non-GAAP diluted EPS
Initiated
Full year 2023
|
$2.25 – $2.55 | Non-GAAP | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 10, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed May 10, 2023 · complete as-filed document